Toyota|$17.83 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$24.05 (¥3,814)+2.91%▲ (in JPY terms)
SoftBank|$36.59 (¥5,803)-3.92%▼ (in JPY terms)
MUFG|$21.83 (¥3,462)-1.20%▼ (in JPY terms)
Keyence|$507.86 (¥80,540)+0.68%▲ (in JPY terms)
Nintendo|$51.37 (¥8,146)+3.76%▲ (in JPY terms)
NTT|$1.09 (¥173)+0.46%▲ (in JPY terms)
Takeda|$36.84 (¥5,843)+0.46%▲ (in JPY terms)
Tokyo Electron|$78.47 (¥12,445)+2.09%▲ (in JPY terms)
Recruit|$111.96 (¥17,755)+3.23%▲ (in JPY terms)
ITOCHU|$13.59 (¥2,155)+0.77%▲ (in JPY terms)
Honda|$10.89 (¥1,727)+0.82%▲ (in JPY terms)
Shin-Etsu|$38.37 (¥6,085)-0.59%▼ (in JPY terms)
Tokio Marine|$3.31 (¥526)+1.47%▲ (in JPY terms)
Fast Retailing|$452.62 (¥71,780)-4.04%▼ (in JPY terms)
Toyota|$17.83 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$24.05 (¥3,814)+2.91%▲ (in JPY terms)
SoftBank|$36.59 (¥5,803)-3.92%▼ (in JPY terms)
MUFG|$21.83 (¥3,462)-1.20%▼ (in JPY terms)
Keyence|$507.86 (¥80,540)+0.68%▲ (in JPY terms)
Nintendo|$51.37 (¥8,146)+3.76%▲ (in JPY terms)
NTT|$1.09 (¥173)+0.46%▲ (in JPY terms)
Takeda|$36.84 (¥5,843)+0.46%▲ (in JPY terms)
Tokyo Electron|$78.47 (¥12,445)+2.09%▲ (in JPY terms)
Recruit|$111.96 (¥17,755)+3.23%▲ (in JPY terms)
ITOCHU|$13.59 (¥2,155)+0.77%▲ (in JPY terms)
Honda|$10.89 (¥1,727)+0.82%▲ (in JPY terms)
Shin-Etsu|$38.37 (¥6,085)-0.59%▼ (in JPY terms)
Tokio Marine|$3.31 (¥526)+1.47%▲ (in JPY terms)
Fast Retailing|$452.62 (¥71,780)-4.04%▼ (in JPY terms)

2026-08-13 Otsuka Holdings Co.,Ltd. “In an interim analysis of the Phase III REZILIENT3 trial in the group receiving diparereltinib in combination with chemotherapy for first-line treatment of non-small cell lung cancer with EGFR exon 20 insertion mutations, the primary endpoint of progression-free survival was achieved.”

2026-08-13 Otsuka Holdings Co.,Ltd. “In an interim analysis of the Phase III REZILIENT3 trial in the group receiving diparereltinib in combination with chemotherapy for first-line treatment of non-small cell lung cancer with EGFR exon 20 insertion mutations, the primary endpoint of progression-free survival was achieved.”

コメントする